BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krautkramer KA, Fan J, Bäckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol 2021;19:77-94. [PMID: 32968241 DOI: 10.1038/s41579-020-0438-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 55] [Article Influence: 22.5] [Reference Citation Analysis]
Number Citing Articles
1 Anesi A, Berding K, Clarke G, Stanton C, Cryan JF, Caplice N, Ross RP, Doolan A, Vrhovsek U, Mattivi F. Metabolomic Workflow for the Accurate and High-Throughput Exploration of the Pathways of Tryptophan, Tyrosine, Phenylalanine, and Branched-Chain Amino Acids in Human Biofluids. J Proteome Res 2022. [PMID: 35380444 DOI: 10.1021/acs.jproteome.1c00946] [Reference Citation Analysis]
2 Guo Y, Zhu G, Wang F, Zhang H, Chen X, Mao Y, Lv Y, Xia F, Jin Y, Ding G, Yu J. Distinct Serum and Fecal Metabolite Profiles Linking With Gut Microbiome in Older Adults With Frailty. Front Med 2022;9:827174. [DOI: 10.3389/fmed.2022.827174] [Reference Citation Analysis]
3 McMurdie PJ, Stoeva MK, Justice N, Nemchek M, Sieber CMK, Tyagi S, Gines J, Skennerton CT, Souza M, Kolterman O, Eid J. Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes. BMC Microbiol 2022;22:19. [PMID: 34996347 DOI: 10.1186/s12866-021-02415-8] [Reference Citation Analysis]
4 Cubillos-Ruiz A, Guo T, Sokolovska A, Miller PF, Collins JJ, Lu TK, Lora JM. Engineering living therapeutics with synthetic biology. Nat Rev Drug Discov 2021;20:941-60. [PMID: 34616030 DOI: 10.1038/s41573-021-00285-3] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Zhong X, Cui P, Jiang J, Ning C, Liang B, Zhou J, Tian L, Zhang Y, Lei T, Zuo T, Ye L, Huang J, Chen H. Streptococcus, the Predominant Bacterium to Predict the Severity of Liver Injury in Alcoholic Liver Disease. Front Cell Infect Microbiol 2021;11:649060. [PMID: 33816353 DOI: 10.3389/fcimb.2021.649060] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Gu BH, Kim M, Yun CH. Regulation of Gastrointestinal Immunity by Metabolites. Nutrients 2021;13:E167. [PMID: 33430497 DOI: 10.3390/nu13010167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wang D, Doestzada M, Chen L, Andreu-Sánchez S, van den Munckhof ICL, Augustijn HE, Koehorst M, Ruiz-Moreno AJ, Bloks VW, Riksen NP, Rutten JHW, Joosten LAB, Netea MG, Wijmenga C, Zhernakova A, Kuipers F, Fu J. Characterization of gut microbial structural variations as determinants of human bile acid metabolism. Cell Host Microbe 2021;29:1802-1814.e5. [PMID: 34847370 DOI: 10.1016/j.chom.2021.11.003] [Reference Citation Analysis]
8 Paquet JC, Claus SP, Cordaillat-Simmons M, Mazier W, Rawadi G, Rinaldi L, Elustondo F, Rouanet A. Entering First-in-Human Clinical Study With a Single-Strain Live Biotherapeutic Product: Input and Feedback Gained From the EMA and the FDA. Front Med (Lausanne) 2021;8:716266. [PMID: 34458291 DOI: 10.3389/fmed.2021.716266] [Reference Citation Analysis]
9 Sun QH, Liu ZJ, Zhang L, Wei H, Song LJ, Zhu SW, He MB, Duan LP. Sex-based differences in fecal short-chain fatty acid and gut microbiota in irritable bowel syndrome patients. J Dig Dis 2021;22:246-55. [PMID: 33822477 DOI: 10.1111/1751-2980.12988] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Melekoglu E, Cetinkaya MA, Kepekci-Tekkeli SE, Kul O, Samur G. Effects of prebiotic oligofructose-enriched inulin on gut-derived uremic toxins and disease progression in rats with adenine-induced chronic kidney disease. PLoS One 2021;16:e0258145. [PMID: 34614017 DOI: 10.1371/journal.pone.0258145] [Reference Citation Analysis]
11 Arora T, Tremaroli V. Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes. Front Endocrinol (Lausanne) 2021;12:761834. [PMID: 34737725 DOI: 10.3389/fendo.2021.761834] [Reference Citation Analysis]
12 Scarborough MJ, Lawson CE, DeCola AC, Gois IM. Microbiomes for sustainable biomanufacturing. Curr Opin Microbiol 2021;65:8-14. [PMID: 34700205 DOI: 10.1016/j.mib.2021.09.015] [Reference Citation Analysis]
13 Borella F, Carosso AR, Cosma S, Preti M, Collemi G, Cassoni P, Bertero L, Benedetto C. Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions. ACS Infect Dis 2021;7:987-1009. [PMID: 33848139 DOI: 10.1021/acsinfecdis.0c00839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Zheng X, Cai X, Hao H. Emerging targetome and signalome landscape of gut microbial metabolites. Cell Metab 2022;34:35-58. [PMID: 34986337 DOI: 10.1016/j.cmet.2021.12.011] [Reference Citation Analysis]
15 Zhang H, Liu X, Zheng Y, Zha X, Elsabagh M, Zhang Y, Ma Y, Loor JJ, Wang M, Wang H. Effects of the maternal gut microbiome and gut-placental axis on melatonin efficacy in alleviating cadmium-induced fetal growth restriction. Ecotoxicol Environ Saf 2022;237:113550. [PMID: 35487173 DOI: 10.1016/j.ecoenv.2022.113550] [Reference Citation Analysis]
16 Bongiovanni T, Yin MOL, Heaney L. The Athlete and Gut Microbiome: Short-chain Fatty Acids as Potential Ergogenic Aids for Exercise and Training. Int J Sports Med 2021. [PMID: 34256388 DOI: 10.1055/a-1524-2095] [Reference Citation Analysis]
17 Mirzaei R, Dehkhodaie E, Bouzari B, Rahimi M, Gholestani A, Hosseini-Fard SR, Keyvani H, Teimoori A, Karampoor S. Dual role of microbiota-derived short-chain fatty acids on host and pathogen. Biomed Pharmacother 2022;145:112352. [PMID: 34840032 DOI: 10.1016/j.biopha.2021.112352] [Reference Citation Analysis]
18 Lindell AE, Zimmermann-kogadeeva M, Patil KR. Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota. Nat Rev Microbiol. [DOI: 10.1038/s41579-022-00681-5] [Reference Citation Analysis]
19 [DOI: 10.1101/2020.11.13.20231209] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Stražar M, Mourits VP, Koeken VACM, de Bree LCJ, Moorlag SJCFM, Joosten LAB, van Crevel R, Vlamakis H, Netea MG, Xavier RJ. The influence of the gut microbiome on BCG-induced trained immunity. Genome Biol 2021;22:275. [PMID: 34551799 DOI: 10.1186/s13059-021-02482-0] [Reference Citation Analysis]
21 Mcnamara MP, Cadney MD, Castro AA, Hillis DA, Kallini KM, Macbeth JC, Schmill MP, Schwartz NE, Hsiao A, Garland T. Oral antibiotics reduce voluntary exercise behavior in athletic mice. Behavioural Processes 2022. [DOI: 10.1016/j.beproc.2022.104650] [Reference Citation Analysis]
22 Pandey P, Khan F, Maurya P. Targeting Jab1 using hesperidin (dietary phytocompound) for inducing apoptosis in HeLa cervical cancer cells. J Food Biochem 2021;45:e13800. [PMID: 34047379 DOI: 10.1111/jfbc.13800] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Raybould HE, Zumpano DL. Microbial metabolites and the vagal afferent pathway in the control of food intake. Physiol Behav 2021;240:113555. [PMID: 34375620 DOI: 10.1016/j.physbeh.2021.113555] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Pu J, Liu Y, Gui S, Tian L, Yu Y, Song X, Zhong X, Chen X, Chen W, Zheng P, Zhang H, Gong X, Liu L, Wu J, Wang H, Xie P. Metabolomic changes in animal models of depression: a systematic analysis. Mol Psychiatry 2021. [PMID: 34471249 DOI: 10.1038/s41380-021-01269-w] [Reference Citation Analysis]
25 Martínez-garcía JJ, Rainteau D, Humbert L, Lamaziere A, Lesnik P, Chamaillard M. Diurnal Interplay between Epithelium Physiology and Gut Microbiota as a Metronome for Orchestrating Immune and Metabolic Homeostasis. Metabolites 2022;12:390. [DOI: 10.3390/metabo12050390] [Reference Citation Analysis]
26 Mullish BH, Allegretti JR. The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection. Therap Adv Gastroenterol 2021;14:17562848211017725. [PMID: 34104212 DOI: 10.1177/17562848211017725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Tröscher-Mußotter J, Saenz JS, Grindler S, Meyer J, Kononov SU, Mezger B, Borda-Molina D, Frahm J, Dänicke S, Camarinha-Silva A, Huber K, Seifert J. Microbiome Clusters Disclose Physiologic Variances in Dairy Cows Challenged by Calving and Lipopolysaccharides. mSystems 2021;6:e0085621. [PMID: 34665011 DOI: 10.1128/mSystems.00856-21] [Reference Citation Analysis]
28 Kviatcovsky D, Zheng D, Elinav E. Gut microbiome and its potential link to personalized nutrition. Current Opinion in Physiology 2021;22:100439. [DOI: 10.1016/j.cophys.2021.05.002] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clin Microbiol Rev 2022;:e0033820. [PMID: 34985325 DOI: 10.1128/CMR.00338-20] [Reference Citation Analysis]
30 Gebrayel P, Nicco C, Al Khodor S, Bilinski J, Caselli E, Comelli EM, Egert M, Giaroni C, Karpinski TM, Loniewski I, Mulak A, Reygner J, Samczuk P, Serino M, Sikora M, Terranegra A, Ufnal M, Villeger R, Pichon C, Konturek P, Edeas M. Microbiota medicine: towards clinical revolution. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03296-9] [Reference Citation Analysis]
31 Zhang S, Zhu J. Untargeted Metabolomics Sensitively Differentiates Gut Bacterial Species in Single Culture and Co-Culture Systems. ACS Omega. [DOI: 10.1021/acsomega.1c07114] [Reference Citation Analysis]
32 Pu J, Liu Y, Gui S, Tian L, Yu Y, Wang D, Zhong X, Chen W, Chen X, Chen Y, Chen X, Gong X, Liu L, Li W, Wang H, Xie P. Effects of pharmacological treatment on metabolomic alterations in animal models of depression. Transl Psychiatry 2022;12:175. [PMID: 35487889 DOI: 10.1038/s41398-022-01947-5] [Reference Citation Analysis]
33 Hoozemans J, de Brauw M, Nieuwdorp M, Gerdes V. Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review. Metabolites 2021;11:353. [PMID: 34072995 DOI: 10.3390/metabo11060353] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Salekeen R, Siam MHB, Sharif DI, Lustgarten MS, Billah MM, Islam KMD. In silico insights into potential gut microbial modulation of NAD+ metabolism and longevity. J Biochem Mol Toxicol 2021;:e22925. [PMID: 34580953 DOI: 10.1002/jbt.22925] [Reference Citation Analysis]
35 Caffaratti C, Plazy C, Mery G, Tidjani AR, Fiorini F, Thiroux S, Toussaint B, Hannani D, Le Gouellec A. What We Know So Far about the Metabolite-Mediated Microbiota-Intestinal Immunity Dialogue and How to Hear the Sound of This Crosstalk. Metabolites 2021;11:406. [PMID: 34205653 DOI: 10.3390/metabo11060406] [Reference Citation Analysis]
36 Herrera G, Paredes-Sabja D, Patarroyo MA, Ramírez JD, Muñoz M. Updating changes in human gut microbial communities associated with Clostridioides difficile infection. Gut Microbes 2021;13:1966277. [PMID: 34486488 DOI: 10.1080/19490976.2021.1966277] [Reference Citation Analysis]
37 Liu Q, Li B, Li Y, Wei Y, Huang B, Liang J, You Z, Li Y, Qian Q, Wang R, Zhang J, Chen R, Lyu Z, Chen Y, Shi M, Xiao X, Wang Q, Miao Q, Fang JY, Gershwin ME, Lian M, Ma X, Tang R. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut 2021:gutjnl-2020-323565. [PMID: 34035120 DOI: 10.1136/gutjnl-2020-323565] [Reference Citation Analysis]
38 Kinashi Y, Hase K. Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity. Front Immunol 2021;12:673708. [PMID: 33968085 DOI: 10.3389/fimmu.2021.673708] [Reference Citation Analysis]
39 Harrison XA, McDevitt AD, Dunn JC, Griffiths SM, Benvenuto C, Birtles R, Boubli JP, Bown K, Bridson C, Brooks DR, Browett SS, Carden RF, Chantrey J, Clever F, Coscia I, Edwards KL, Ferry N, Goodhead I, Highlands A, Hopper J, Jackson J, Jehle R, da Cruz Kaizer M, King T, Lea JMD, Lenka JL, McCubbin A, McKenzie J, de Moraes BLC, O'Meara DB, Pescod P, Preziosi RF, Rowntree JK, Shultz S, Silk MJ, Stockdale JE, Symondson WOC, de la Pena MV, Walker SL, Wood MD, Antwis RE. Fungal microbiomes are determined by host phylogeny and exhibit widespread associations with the bacterial microbiome. Proc Biol Sci 2021;288:20210552. [PMID: 34403636 DOI: 10.1098/rspb.2021.0552] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Rajković E, Schwarz C, Tischler D, Schedle K, Reisinger N, Emsenhuber C, Ocelova V, Roth N, Frieten D, Dusel G, Gierus M. Potential of Grape Extract in Comparison with Therapeutic Dosage of Antibiotics in Weaning Piglets: Effects on Performance, Digestibility and Microbial Metabolites of the Ileum and Colon. Animals (Basel) 2021;11:2771. [PMID: 34679793 DOI: 10.3390/ani11102771] [Reference Citation Analysis]
41 Santos-laso A, Gutiérrez-larrañaga M, Alonso-peña M, Medina JM, Iruzubieta P, Arias-loste MT, López-hoyos M, Crespo J. Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets. Biomedicines 2022;10:46. [DOI: 10.3390/biomedicines10010046] [Reference Citation Analysis]
42 Luo Y, Zhou T. Connecting the dots: Targeting the microbiome in drug toxicity. Med Res Rev 2021. [PMID: 33856076 DOI: 10.1002/med.21805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Parolin C, Zhu W, Zhu J. Editorial: Metabolomics of Human Microbiome Studies: Recent Advances in Methods and Applications. Front Mol Biosci 2021;8:800337. [PMID: 34917651 DOI: 10.3389/fmolb.2021.800337] [Reference Citation Analysis]
44 Meng Z, Sun W, Liu W, Wang Y, Jia M, Tian S, Chen X, Zhu W, Zhou Z. A common fungicide tebuconazole promotes colitis in mice via regulating gut microbiota. Environ Pollut 2022;292:118477. [PMID: 34763016 DOI: 10.1016/j.envpol.2021.118477] [Reference Citation Analysis]
45 Xu X, Zhang W, Guo M, Xiao C, Fu Z, Yu S, Jiang L, Wang S, Ling Y, Liu F, Tan Y, Chen S. Integrated analysis of gut microbiome and host immune responses in COVID-19. Front Med 2022. [PMID: 35258762 DOI: 10.1007/s11684-022-0921-6] [Reference Citation Analysis]
46 Xu X, Sun S, Liang L, Lou C, He Q, Ran M, Zhang L, Zhang J, Yan C, Yuan H, Zhou L, Chen X, Dai X, Wang B, Zhang J, Zhao J. Role of the Aryl Hydrocarbon Receptor and Gut Microbiota-Derived Metabolites Indole-3-Acetic Acid in Sulforaphane Alleviates Hepatic Steatosis in Mice. Front Nutr 2021;8:756565. [PMID: 34722615 DOI: 10.3389/fnut.2021.756565] [Reference Citation Analysis]
47 Xiao X, Cheng Y, Fu J, Lu Z, Wang F, Jin M, Zong X, Wang Y. Gut Immunity and Microbiota Dysbiosis Are Associated with Altered Bile Acid Metabolism in LPS-Challenged Piglets. Oxid Med Cell Longev 2021;2021:6634821. [PMID: 33833852 DOI: 10.1155/2021/6634821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Mohamed AB, Rémond D, Gual-Grau A, Bernalier-Donnadille A, Capel F, Michalski MC, Laugerette F, Cohade B, Hafnaoui N, Béchet D, Coudy-Gandilhon C, Gueugneau M, Salles J, Migné C, Dardevet D, David J, Polakof S, Savary-Auzeloux I. A Mix of Dietary Fibres Changes Interorgan Nutrients Exchanges and Muscle-Adipose Energy Handling in Overfed Mini-Pigs. Nutrients 2021;13:4202. [PMID: 34959754 DOI: 10.3390/nu13124202] [Reference Citation Analysis]
49 Peng Y, Nie Y, Yu J, Wong CC. Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications. Metabolites 2021;11:159. [PMID: 33802045 DOI: 10.3390/metabo11030159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Fang G, Chai L, Zhong X, Lu Z, Zhang X, Wu L, Wang S, Shen C, Shi J, Xu Z, Lal R. Comparative Genomics Unveils the Habitat Adaptation and Metabolic Profiles of Clostridium in an Artificial Ecosystem for Liquor Production. mSystems. [DOI: 10.1128/msystems.00297-22] [Reference Citation Analysis]
51 Le Magueresse-Battistoni B. Adipose Tissue and Endocrine-Disrupting Chemicals: Does Sex Matter? Int J Environ Res Public Health 2020;17:E9403. [PMID: 33333918 DOI: 10.3390/ijerph17249403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Saito T, Wei Y, Wen L, Srinivasan C, Wolthers BO, Tsai CY, Harris MH, Stevenson K, Byersdorfer C, Oparaji JA, Fernandez C, Mukherjee A, Abu-El-Haija M, Agnihotri S, Schmiegelow K, Showalter MR, Fogle PW, McCulloch S, Contrepois K, Silverman LB, Ding Y, Husain SZ. Impact of acute lymphoblastic leukemia induction therapy: findings from metabolomics on non-fasted plasma samples from a biorepository. Metabolomics 2021;17:64. [PMID: 34175981 DOI: 10.1007/s11306-021-01814-2] [Reference Citation Analysis]
53 Gupta H, Min B, Ganesan R, Gebru YA, Sharma SP, Park E, Won S, Jeong J, Lee S, Cha M, Kwon G, Jeong M, Hyun J, Eom J, Park H, Yoon S, Choi M, Kim D, Suk K. Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role. Biomedicines 2022;10:550. [DOI: 10.3390/biomedicines10030550] [Reference Citation Analysis]
54 Huang W, Yan Y, Wu M, Hu J, Zhao J, Chen X, Liu W, Liu K, Li C. Preoperative fasting confers protection against intestinal ischaemia/reperfusion injury by modulating gut microbiota and their metabolites in a mouse model. Br J Anaesth 2021:S0007-0912(21)00754-6. [PMID: 34930601 DOI: 10.1016/j.bja.2021.11.025] [Reference Citation Analysis]
55 Zhao X, Yang X, Hang HC. Chemoproteomic Analysis of Microbiota Metabolite-Protein Targets and Mechanisms. Biochemistry 2022. [PMID: 34989554 DOI: 10.1021/acs.biochem.1c00758] [Reference Citation Analysis]
56 Panwar RB, Sequeira RP, Clarke TB. Microbiota-mediated protection against antibiotic-resistant pathogens. Genes Immun 2021. [PMID: 33947987 DOI: 10.1038/s41435-021-00129-5] [Reference Citation Analysis]
57 Boyajian JL, Ghebretatios M, Schaly S, Islam P, Prakash S. Microbiome and Human Aging: Probiotic and Prebiotic Potentials in Longevity, Skin Health and Cellular Senescence. Nutrients 2021;13:4550. [PMID: 34960102 DOI: 10.3390/nu13124550] [Reference Citation Analysis]
58 Zhang Z, Wang Y, Zhang Y, Chen K, Chang H, Ma C, Jiang S, Huo D, Liu W, Jha R, Zhang J. Synergistic Effects of the Jackfruit Seed Sourced Resistant Starch and Bifidobacterium pseudolongum subsp. globosum on Suppression of Hyperlipidemia in Mice. Foods 2021;10:1431. [PMID: 34205515 DOI: 10.3390/foods10061431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Espírito Santo C, Caseiro C, Martins MJ, Monteiro R, Brandão I. Gut Microbiota, in the Halfway between Nutrition and Lung Function. Nutrients 2021;13:1716. [PMID: 34069415 DOI: 10.3390/nu13051716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Zou YT, Zhou J, Zhu JH, Wu CY, Shen H, Zhang W, Zhou SS, Xu JD, Mao Q, Zhang YQ, Long F, Li SL. Gut Microbiota Mediates the Protective Effects of Traditional Chinese Medicine Formula Qiong-Yu-Gao against Cisplatin-Induced Acute Kidney Injury. Microbiol Spectr 2022;:e0075922. [PMID: 35481834 DOI: 10.1128/spectrum.00759-22] [Reference Citation Analysis]
61 Hosseinkhani F, Heinken A, Thiele I, Lindenburg PW, Harms AC, Hankemeier T. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. Gut Microbes 2021;13:1-22. [PMID: 33590776 DOI: 10.1080/19490976.2021.1882927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
62 Philips CA, Augustine P. Gut Barrier and Microbiota in Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.08.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Dapa T, Ramiro RS, Pedro MF, Gordo I, Xavier KB. Diet leaves a genetic signature in a keystone member of the gut microbiota. Cell Host Microbe 2022:S1931-3128(22)00038-5. [PMID: 35085504 DOI: 10.1016/j.chom.2022.01.002] [Reference Citation Analysis]
64 Zhang CY, Tan ZJ. Preliminary study on theory of spleen injury caused by exogenous cold and dampness based on intestinal microecology. Shijie Huaren Xiaohua Zazhi 2021; 29(7): 325-331 [DOI: 10.11569/wcjd.v29.i7.325] [Reference Citation Analysis]
65 Guo J, Zhang M, Wang H, Li N, Lu Z, Li L, Hui S, Xu H. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice. J Food Biochem 2022;:e14063. [PMID: 35128673 DOI: 10.1111/jfbc.14063] [Reference Citation Analysis]
66 Sundaram S, Borthakur A. Altered intestinal epithelial nutrient transport: an underappreciated factor in obesity modulated by diet and microbiota. Biochem J 2021;478:975-95. [PMID: 33661278 DOI: 10.1042/BCJ20200902] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Han H, Yi B, Zhong R, Wang M, Zhang S, Ma J, Yin Y, Yin J, Chen L, Zhang H. From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators. Microbiome 2021;9:162. [PMID: 34284827 DOI: 10.1186/s40168-021-01093-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Liu Y, Wang C, Qi S, Wu F. Gut Microbiota Provides a New Mechanism for Explaining Agrochemical-Induced Synergistic Effects on Bee Mortality. Environ Sci Technol 2022. [PMID: 35020385 DOI: 10.1021/acs.est.1c08406] [Reference Citation Analysis]
69 Lu Y, Chong J, Shen S, Chammas JB, Chalifour L, Xia J. TrpNet: Understanding Tryptophan Metabolism across Gut Microbiome. Metabolites 2021;12:10. [PMID: 35050132 DOI: 10.3390/metabo12010010] [Reference Citation Analysis]
70 Nathan C. Nonresolving inflammation redux. Immunity 2022;55:592-605. [PMID: 35417674 DOI: 10.1016/j.immuni.2022.03.016] [Reference Citation Analysis]
71 Leigh SJ, Lynch CMK, Bird BRH, Griffin BT, Cryan JF, Clarke G. Gut microbiota-drug interactions in cancer pharmacotherapies: implications for efficacy and adverse effects. Expert Opin Drug Metab Toxicol 2022. [PMID: 35176217 DOI: 10.1080/17425255.2022.2043849] [Reference Citation Analysis]
72 Liao HY, Wang CY, Lee CH, Kao HL, Wu WK, Kuo CH. Development of an Efficient and Sensitive Chemical Derivatization-Based LC-MS/MS Method for Quantifying Gut Microbiota-Derived Metabolites in Human Plasma and Its Application in Studying Cardiovascular Disease. J Proteome Res 2021;20:3508-18. [PMID: 34053222 DOI: 10.1021/acs.jproteome.1c00147] [Reference Citation Analysis]
73 Song X, Wang L, Liu Y, Zhang X, Weng P, Liu L, Zhang R, Wu Z. The gut microbiota–brain axis: Role of the gut microbial metabolites of dietary food in obesity. Food Research International 2022. [DOI: 10.1016/j.foodres.2022.110971] [Reference Citation Analysis]
74 Wang B, Zhang L, Wang Y, Dai T, Qin Z, Zhou F, Zhang L. Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal Transduct Target Ther 2022;7:143. [PMID: 35487886 DOI: 10.1038/s41392-022-00986-0] [Reference Citation Analysis]
75 Rampelli S, Turroni S, Debandi F, Alberdi A, Schnorr SL, Hofman CA, Taddia A, Helg R, Biagi E, Brigidi P, D'Amico F, Cattani M, Candela M. The gut microbiome buffers dietary adaptation in Bronze Age domesticated dogs. iScience 2021;24:102816. [PMID: 34377966 DOI: 10.1016/j.isci.2021.102816] [Reference Citation Analysis]
76 Wang L, Cheng X, Bai L, Gao M, Kang G, Cao X, Huang H. Positive Interventional Effect of Engineered Butyrate-Producing Bacteria on Metabolic Disorders and Intestinal Flora Disruption in Obese Mice. Microbiol Spectr 2022;:e0114721. [PMID: 35293806 DOI: 10.1128/spectrum.01147-21] [Reference Citation Analysis]
77 Bubier JA, Chesler EJ, Weinstock GM. Host genetic control of gut microbiome composition. Mamm Genome 2021;32:263-81. [PMID: 34159422 DOI: 10.1007/s00335-021-09884-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Chen J, Vitetta L, Henson JD, Hall S. Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis. Int J�Tryptophan�Res 2022;15:117864692110705. [DOI: 10.1177/11786469211070533] [Reference Citation Analysis]
79 Liu R, Peng C, Jing D, Xiao Y, Zhu W, Zhao S, Zhang J, Chen X, Li J. Lachnospira is a signature of antihistamine efficacy in chronic spontaneous urticaria. Exp Dermatol 2021. [PMID: 34558729 DOI: 10.1111/exd.14460] [Reference Citation Analysis]
80 Wu Y, Wu Y, Wu H, Wu C, Ji E, Xu J, Zhang Y, Wei J, Zhao Y, Yang H. Systematic Survey of the Alteration of the Faecal Microbiota in Rats With Gastrointestinal Disorder and Modulation by Multicomponent Drugs. Front Pharmacol 2021;12:670335. [PMID: 34803663 DOI: 10.3389/fphar.2021.670335] [Reference Citation Analysis]
81 Zhao T, Zhan L, Zhou W, Chen W, Luo J, Zhang L, Weng Z, Zhao C, Liu S. The Effects of Erchen Decoction on Gut Microbiota and Lipid Metabolism Disorders in Zucker Diabetic Fatty Rats. Front Pharmacol 2021;12:647529. [PMID: 34366839 DOI: 10.3389/fphar.2021.647529] [Reference Citation Analysis]
82 He Y, Zhang Y, Li F, Shi Y. White Matter Injury in Preterm Infants: Pathogenesis and Potential Therapy From the Aspect of the Gut–Brain Axis. Front Neurosci 2022;16:849372. [DOI: 10.3389/fnins.2022.849372] [Reference Citation Analysis]
83 Wirusanti NI, Baldridge MT, Harris VC. Microbiota regulation of viral infections through interferon signaling. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.01.007] [Reference Citation Analysis]
84 Gawałko M, Agbaedeng TA, Saljic A, Müller DN, Wilck N, Schnabel R, Penders J, Rienstra M, van Gelder I, Jespersen T, Schotten U, Crijns HJGM, Kalman JM, Sanders P, Nattel S, Dobrev D, Linz D. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications. Cardiovasc Res 2021:cvab292. [PMID: 34550344 DOI: 10.1093/cvr/cvab292] [Reference Citation Analysis]
85 Sakanaka A, Kuboniwa M, Katakami N, Furuno M, Nishizawa H, Omori K, Taya N, Ishikawa A, Mayumi S, Tanaka Isomura E, Shimomura I, Fukusaki E, Amano A. Saliva and Plasma Reflect Metabolism Altered by Diabetes and Periodontitis. Front Mol Biosci 2021;8:742002. [PMID: 34589520 DOI: 10.3389/fmolb.2021.742002] [Reference Citation Analysis]
86 Cheng P, Shen P, Shan Y, Yang Y, Deng R, Chen W, Lu Y, Wei Z. Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy. Front Cell Dev Biol 2021;9:626045. [PMID: 34568308 DOI: 10.3389/fcell.2021.626045] [Reference Citation Analysis]
87 Priyadarshini M, Lednovich K, Xu K, Gough S, Wicksteed B, Layden BT. FFAR from the Gut Microbiome Crowd: SCFA Receptors in T1D Pathology. Metabolites 2021;11:302. [PMID: 34064625 DOI: 10.3390/metabo11050302] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Zheng Y, Pang X, Zhu X, Meng Z, Chen X, Zhang J, Ding Q, Li Q, Dou G, Ma B. Lycium barbarum mitigates radiation injury via regulation of the immune function, gut microbiota, and related metabolites. Biomed Pharmacother 2021;139:111654. [PMID: 33957563 DOI: 10.1016/j.biopha.2021.111654] [Reference Citation Analysis]
89 Iyer N, Corr SC. Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease. Nutrients 2021;13:4259. [PMID: 34959809 DOI: 10.3390/nu13124259] [Reference Citation Analysis]
90 De Giani A, Bovio F, Forcella ME, Lasagni M, Fusi P, Di Gennaro P. Prebiotic Effect of Maitake Extract on a Probiotic Consortium and Its Action after Microbial Fermentation on Colorectal Cell Lines. Foods 2021;10:2536. [PMID: 34828817 DOI: 10.3390/foods10112536] [Reference Citation Analysis]
91 He J, Liu R, Zheng W, Guo H, Yang Y, Zhao R, Yao W. High ambient temperature exposure during late gestation disrupts glycolipid metabolism and hepatic mitochondrial function tightly related to gut microbial dysbiosis in pregnant mice. Microb Biotechnol 2021. [PMID: 34272826 DOI: 10.1111/1751-7915.13893] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Zhuang Z, Li N, Wang J, Yang R, Wang W, Liu Z, Huang T. GWAS-associated bacteria and their metabolites appear to be causally related to the development of inflammatory bowel disease. Eur J Clin Nutr. [DOI: 10.1038/s41430-022-01074-w] [Reference Citation Analysis]
93 Timasheva YR, Balkhiyarova ZR, Kochetova OV. [Current state of the obesity research: genetic aspects, the role of microbiome, and susceptibility to COVID-19]. Probl Endokrinol (Mosk) 2021;67:20-35. [PMID: 34533011 DOI: 10.14341/probl12775] [Reference Citation Analysis]
94 Chattopadhyay I, Gundamaraju R, Jha NK, Gupta PK, Dey A, Mandal CC, Ford BM, Nicolazzo C. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer? Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/2941248] [Reference Citation Analysis]
95 Hao F, Zhu J, Zhang N, He P, Miao Q, Liu Y, Gao Y, Liu X, Deng G, Zhang Z, Feng M, Zhao L. Association between gut microbiome and metabolome in mice suffering from acute carbapenem-resistant Escherichia coli infection. Journal of Pharmaceutical and Biomedical Analysis 2022. [DOI: 10.1016/j.jpba.2022.114770] [Reference Citation Analysis]
96 Wen Y, Chen H, Luo F, Zhou H, Li Z. Roles of long noncoding RNAs in bacterial infection. Life Sciences 2020;263:118579. [DOI: 10.1016/j.lfs.2020.118579] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
97 Sun X, Cui Q, Ni J, Liu X, Zhu J, Zhou T, Huang H, OuYang K, Wu Y, Yang Z. Gut Microbiota Mediates the Therapeutic Effect of Monoclonal Anti-TLR4 Antibody on Acetaminophen-Induced Acute Liver Injury in Mice. Microbiol Spectr 2022;:e0064722. [PMID: 35536057 DOI: 10.1128/spectrum.00647-22] [Reference Citation Analysis]
98 Goh YQ, Cheam G, Wang Y. Understanding Choline Bioavailability and Utilization: First Step Toward Personalizing Choline Nutrition. J Agric Food Chem 2021. [PMID: 34392687 DOI: 10.1021/acs.jafc.1c03077] [Reference Citation Analysis]
99 Balvers M, Deschasaux M, van den Born BJ, Zwinderman K, Nieuwdorp M, Levin E. Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area. Nutrients 2021;13:3289. [PMID: 34579166 DOI: 10.3390/nu13093289] [Reference Citation Analysis]
100 Monaghan TM, Seekatz AM, Mullish BH, Moore-Gillon CCER, Dawson LF, Ahmed A, Kao D, Chan WC. Clostridioides difficile: innovations in target discovery and potential for therapeutic success. Expert Opin Ther Targets 2021;:1-15. [PMID: 34793686 DOI: 10.1080/14728222.2021.2008907] [Reference Citation Analysis]
101 Sanders DJ, Inniss S, Sebepos-Rogers G, Rahman FZ, Smith AM. The role of the microbiome in gastrointestinal inflammation. Biosci Rep 2021;41:BSR20203850. [PMID: 34076695 DOI: 10.1042/BSR20203850] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Lucerne KE, Osman A, Meckel KR, Kiraly DD. Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders. Neuropharmacology 2021;192:108598. [PMID: 33965398 DOI: 10.1016/j.neuropharm.2021.108598] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
103 Romaní-Pérez M, Bullich-Vilarrubias C, López-Almela I, Liébana-García R, Olivares M, Sanz Y. The Microbiota and the Gut-Brain Axis in Controlling Food Intake and Energy Homeostasis. Int J Mol Sci 2021;22:5830. [PMID: 34072450 DOI: 10.3390/ijms22115830] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
104 Cani PD, Moens de Hase E, Van Hul M. Gut Microbiota and Host Metabolism: From Proof of Concept to Therapeutic Intervention. Microorganisms 2021;9:1302. [PMID: 34203876 DOI: 10.3390/microorganisms9061302] [Reference Citation Analysis]
105 Desselberger U. Significance of the Gut Microbiome for Viral Diarrheal and Extra-Intestinal Diseases. Viruses 2021;13:1601. [PMID: 34452466 DOI: 10.3390/v13081601] [Reference Citation Analysis]
106 Geng Z, Zhu Y, Li Q, Zhao C, Zhou P. Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders. Front Aging Neurosci 2022;14:810483. [DOI: 10.3389/fnagi.2022.810483] [Reference Citation Analysis]
107 Yu D, Du J, Pu X, Zheng L, Chen S, Wang N, Li J, Chen S, Pan S, Shen B. The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis. Front Cell Infect Microbiol 2022;11:763507. [DOI: 10.3389/fcimb.2021.763507] [Reference Citation Analysis]
108 Strassheim D, Sullivan T, Irwin DC, Gerasimovskaya E, Lahm T, Klemm DJ, Dempsey EC, Stenmark KR, Karoor V. Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases. Cells 2021;10:3347. [PMID: 34943862 DOI: 10.3390/cells10123347] [Reference Citation Analysis]
109 Li J, Zhang AH, Wu FF, Wang XJ. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects. Front Oncol 2022;12:841552. [PMID: 35223525 DOI: 10.3389/fonc.2022.841552] [Reference Citation Analysis]
110 Li B, Zhang H, Shi L, Li R, Luo Y, Deng Y, Li S, Li R, Liu Z. Saccharomyces boulardii alleviates DSS-induced intestinal barrier dysfunction and inflammation in humanized mice. Food Funct 2021. [PMID: 34878454 DOI: 10.1039/d1fo02752b] [Reference Citation Analysis]
111 Thänert R, Thänert A, Ou J, Bajinting A, Burnham CD, Engelstad HJ, Tecos ME, Ndao IM, Hall-Moore C, Rouggly-Nickless C, Carl MA, Rubin DC, Davidson NO, Tarr PI, Warner BB, Dantas G, Warner BW. Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections. Gut Microbes 2021;13:1940792. [PMID: 34264786 DOI: 10.1080/19490976.2021.1940792] [Reference Citation Analysis]
112 Xiao L, Liu Q, Luo M, Xiong L. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome. Front Cell Infect Microbiol 2021;11:729346. [PMID: 34631603 DOI: 10.3389/fcimb.2021.729346] [Reference Citation Analysis]